tiprankstipranks
Blurbs

Analysts’ Opinions Are Mixed on These Healthcare Stocks: BellRing Brands (BRBR), Aprea Therapeutics (APRE) and Alpha Teknova (TKNO)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on BellRing Brands (BRBRResearch Report), Aprea Therapeutics (APREResearch Report) and Alpha Teknova (TKNOResearch Report).

BellRing Brands (BRBR)

In a report released today, Kaumil Gajrawala from Credit Suisse maintained a Hold rating on BellRing Brands, with a price target of $26.00. The company’s shares closed last Tuesday at $25.07.

According to TipRanks.com, Gajrawala is a 1-star analyst with an average return of -1.6% and a 48.1% success rate. Gajrawala covers the Consumer Goods sector, focusing on stocks such as Reynolds Consumer Products, Constellation Brands, and Simply Good Foods.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for BellRing Brands with a $31.50 average price target.

See Insiders’ Hot Stocks on TipRanks >>

Aprea Therapeutics (APRE)

In a report released today, Gregory Renza from RBC Capital maintained a Hold rating on Aprea Therapeutics, with a price target of $4.00. The company’s shares closed last Tuesday at $1.74, close to its 52-week low of $1.46.

According to TipRanks.com, Renza ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -4.9% and a 33.8% success rate. Renza covers the Healthcare sector, focusing on stocks such as Global Blood Therapeutics, Verrica Pharmaceuticals, and ACADIA Pharmaceuticals.

Aprea Therapeutics has an analyst consensus of Hold, with a price target consensus of $3.33, representing a 97.0% upside. In a report released today, Berenberg Bank also maintained a Hold rating on the stock with a $4.00 price target.

Alpha Teknova (TKNO)

Stephens analyst Jacob Johnson maintained a Buy rating on Alpha Teknova today and set a price target of $26.00. The company’s shares closed last Tuesday at $14.84, close to its 52-week low of $13.78.

According to TipRanks.com, Johnson is ranked #1003 out of 7784 analysts.

Currently, the analyst consensus on Alpha Teknova is a Moderate Buy with an average price target of $26.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on BRBR:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More